0001209191-22-002943.txt : 20220111 0001209191-22-002943.hdr.sgml : 20220111 20220111180000 ACCESSION NUMBER: 0001209191-22-002943 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220110 FILED AS OF DATE: 20220111 DATE AS OF CHANGE: 20220111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDEL ROGER MD CENTRAL INDEX KEY: 0001093125 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12111 FILM NUMBER: 22524937 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDNAX, INC. CENTRAL INDEX KEY: 0000893949 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOSPITALS [8060] IRS NUMBER: 263667538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 BUSINESS PHONE: 9543840175 MAIL ADDRESS: STREET 1: 1301 CONCORD TERRACE CITY: SUNRISE STATE: FL ZIP: 33323 FORMER COMPANY: FORMER CONFORMED NAME: PEDIATRIX MEDICAL GROUP INC DATE OF NAME CHANGE: 19950801 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-10 0 0000893949 MEDNAX, INC. MD 0001093125 MEDEL ROGER MD 1301 CONCORD TERRACE SUNRISE FL 33323 1 0 0 0 Common Stock 2022-01-10 4 S 0 59893 26.44 D 779557 D Common Stock 2022-01-11 4 S 0 40107 26.58 D 739450 D Sales made pursuant to reporting person's 10b5-1 trading plan adopted August 25, 2021. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.04 to $26.75 for a weighted average sales price of $26.44. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions with prices ranging from $26.14 to $26.96 for a weighted average sales price of $26.58. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Dominic J. Andreano, Attorney-in-Fact 2022-01-11